{"id":11513,"date":"2024-05-22T07:00:00","date_gmt":"2024-05-22T05:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-sander-bolagsstamman-live\/"},"modified":"2024-05-22T07:00:00","modified_gmt":"2024-05-22T05:00:00","slug":"irlab-sander-bolagsstamman-live","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/","title":{"rendered":"IRLAB s\u00e4nder bolagsst\u00e4mman live"},"content":{"rendered":"
\n

G\u00f6teborg den 22 maj, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att s\u00e4nda bolagsst\u00e4mman live via YouTube.<\/strong><\/p>\n<\/div>\n

\n

S\u00e4ndningen sker under f\u00f6ruts\u00e4ttning att ett beslut om att s\u00e4nda st\u00e4mman fattas av bolagsst\u00e4mman. Bolagsst\u00e4mman inleds idag den 22 maj kl 17.00 och uts\u00e4ndningen ber\u00e4knas, f\u00f6r det fall beslut om det fattas, att inledas strax d\u00e4refter.<\/p>\n

S\u00e4ndningen n\u00e5s genom f\u00f6ljande l\u00e4nk:
https:\/\/youtube.com\/live\/1MtKwCnyYr0?feature=share<\/a><\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Viktor Siewertz, CFO
Tel: +46 727 10 70 70
E-post:\u00a0viktor.siewertz@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan hj\u00e4rnans signalsubstanser och CNS-st\u00f6rningar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 balans och fallfrekvens vid Parkinson. Dessutom utvecklar bolaget \u00e4ven de tre prekliniska programmen IRL757 (med finansiering fr\u00e5n Michael J. Fox Foundation), IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB s\u00e4nder bolagsst\u00e4mman live<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg den 22 maj, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att s\u00e4nda bolagsst\u00e4mman live via YouTube.<\/p>\n","protected":false},"template":"","class_list":["post-11513","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB s\u00e4nder bolagsst\u00e4mman live - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB s\u00e4nder bolagsst\u00e4mman live - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg den 22 maj, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att s\u00e4nda bolagsst\u00e4mman live via YouTube.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/\",\"name\":\"IRLAB s\u00e4nder bolagsst\u00e4mman live - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2024-05-22T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB s\u00e4nder bolagsst\u00e4mman live\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB s\u00e4nder bolagsst\u00e4mman live - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB s\u00e4nder bolagsst\u00e4mman live - IRLAB","og_description":"G\u00f6teborg den 22 maj, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelade idag att bolaget kommer att s\u00e4nda bolagsst\u00e4mman live via YouTube.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/","name":"IRLAB s\u00e4nder bolagsst\u00e4mman live - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2024-05-22T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-sander-bolagsstamman-live\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB s\u00e4nder bolagsst\u00e4mman live"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/11513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=11513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}